IndiaAI and National Cancer Grid Launch CATCH Grant Program for AI Innovation in Cancer Care

WhatsApp Channel Join Now
Telegram Group Join Now

IndiaAI and National Cancer Grid have introduced the Cancer AI & Technology Challenge (CATCH) Grant Program, offering grants of up to ₹1 crore for AI-driven advancements in cancer screening, diagnosis, and treatment. Applications are open until September 2, 2025.

Funding Structure and Benefits

  • Pilot Grants: Up to ₹50 lakh per project for up to 10 selected proposals.
  • Scale-Up Grants: Additional ₹1 crore for successful pilot projects for nationwide deployment.
  • Co-Funding: Jointly funded by IndiaAI and NCG.

Focus Areas for AI Solutions

  • AI-enabled cancer screening
  • Diagnostics and imaging analysis
  • Clinical decision support systems
  • Patient engagement platforms
  • Operational efficiency tools
  • Research and data curation technologies

Who Can Apply?

  • Startups and health tech companies
  • Academic and research institutions
  • Public and private hospitals
  • Joint applications from Clinical Leads and Technical Leads are encouraged.

Responsible AI and Deployment Readiness

  • Responsible AI development
  • Clinical validation of solutions
  • Ethical deployment tailored to Indian healthcare needs

Application Deadline and Process

  • Last date to apply: September 2, 2025
  • Application mode: Online portal hosted by IndiaAI and NCG
  • More information & applications: IndiaAI CATCH Program Portal

About IndiaAI and NCG

IndiaAI: An Independent Business Division under the Digital India Corporation (DIC), Ministry of Electronics and IT (MeitY), implementing the IndiaAI Mission to democratize AI and ensure ethical use.

NCG: A network of cancer centers and institutions striving to enhance cancer care standards in India.

Key Takeaways for Competitive Exams

  • IndiaAI and NCG launch CATCH Grant Program for AI-driven cancer innovations.
  • Grant offers up to ₹1 crore for projects in screening, diagnosis, and treatment.
  • Focus areas include AI-enabled cancer screening and patient engagement platforms.
  • Open to startups, research institutions, hospitals, and joint applications.
  • Emphasis on responsible AI development and ethical deployment.

WhatsApp Channel Join Now
Telegram Group Join Now

This will close in 0 seconds

telegram Join Telegram
Join Now Join Now